Upgrade to SI Premium - Free Trial

ADMA Biologics (ADMA)

7.97 -0.01 (0.13%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form 8-K ADMA BIOLOGICS, INC. For: Jun 02 June 2, 2026 4:06 PM - SEC Filing Form 4 ADMA BIOLOGICS, INC. For: May 27 Filed by: Grossman Jerrold B May 28, 2026 4:50 PM - SEC Filing Form 4 ADMA BIOLOGICS, INC. For: May 12 Filed by: Grossman Jerrold B May 14, 2026 7:01 AM - SEC Filing Form 4 ADMA BIOLOGICS, INC. For: May 11 Filed by: Grossman Jerrold B May 12, 2026 5:23 PM - SEC Filing ADMA Biologics Investors Should Contact Block & Leviton to Possibly Recover Losses Through The Firm's Investigation May 11, 2026 1:48 PM - StreetInsider ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics Investors May 7, 2026 9:26 AM - StreetInsider ADMA Biologics Investigated for Securities Fraud; Investors Should Contact Block & Leviton to Possibly Recover Losses May 7, 2026 8:22 AM - StreetInsider ADMA Biologics (ADMA) PT Lowered to $20 at Mizuho May 7, 2026 6:49 AM - StreetInsider ADMA Biologics (ADMA) PT Lowered to $18 at Canaccord May 7, 2026 6:38 AM - StreetInsider Form 10-Q ADMA BIOLOGICS, INC. For: Mar 31 May 6, 2026 5:17 PM - SEC Filing ADMA Biologics (ADMA) Misses Q1 EPS by 1c, Offers Guidance May 6, 2026 4:50 PM - StreetInsider Form 8-K ADMA BIOLOGICS, INC. For: May 06 May 6, 2026 4:12 PM - SEC Filing ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update May 6, 2026 4:05 PM - StreetInsider Form 8-K ADMA BIOLOGICS, INC. For: May 04 May 4, 2026 7:06 AM - SEC Filing ADMA Biologics receives FDA approval to expand ASCENIV label for pediatric use May 4, 2026 7:00 AM - StreetInsider ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older May 4, 2026 7:00 AM - Globe NewsWire Form SCHEDULE 13G ADMA BIOLOGICS, INC. Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 29, 2026 4:29 PM - SEC Filing ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026 April 29, 2026 7:00 AM - Globe NewsWire Canaccord Starts ADMA Biologics (ADMA) at Buy April 20, 2026 4:15 PM - StreetInsider Form ARS ADMA BIOLOGICS, INC. For: Dec 31 April 15, 2026 4:40 PM - SEC Filing Form DEFA14A ADMA BIOLOGICS, INC. April 15, 2026 4:36 PM - SEC Filing Form DEF 14A ADMA BIOLOGICS, INC. For: Jun 02 April 15, 2026 4:31 PM - SEC Filing ADMA Biologics (ADMA) PT Lowered to $24 at Mizuho April 13, 2026 6:49 AM - StreetInsider Form 4 ADMA BIOLOGICS, INC. For: Apr 01 Filed by: Kestenberg-Messina Kaitlin M. April 3, 2026 9:01 PM - SEC Filing Increasing unusual call option volume: ADMA CANE DBA PTEN PRCT COUR JBS March 30, 2026 1:49 AM - StreetInsider Form 8-K ADMA BIOLOGICS, INC. For: Mar 27 March 27, 2026 7:06 AM - SEC Filing ADMA Biologics refutes short seller allegations about products March 27, 2026 7:00 AM - StreetInsider ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research March 27, 2026 7:00 AM - StreetInsider Form SCHEDULE 13G/A ADMA BIOLOGICS, INC. Filed by: VANGUARD GROUP INC March 26, 2026 3:12 PM - SEC Filing ADMA Biologics (ADMA) June 10 and 15 calls active, share price down 18.4% March 26, 2026 2:43 PM - StreetInsider Increasing unusual call option volume: ADMA MLCO ESTC NEXT BZAI JBS CHPT NAVN TERN March 26, 2026 10:24 AM - StreetInsider Cantor Fitzgerald Downgrades ADMA Biologics (ADMA) to Neutral March 26, 2026 3:46 AM - StreetInsider ADMA Biologics disputes short-seller report claims March 25, 2026 6:31 AM - StreetInsider ADMA Biologics Addresses Misleading Short-Seller Report March 25, 2026 6:30 AM - StreetInsider ADMA Biologics shares plunge on short seller allegations March 24, 2026 1:52 PM - StreetInsider Culper Research is short ADMA Biologics (ADMA) March 24, 2026 1:36 PM - StreetInsider Form 4 ADMA BIOLOGICS, INC. For: Mar 13 Filed by: Guiheen Lawrence P. March 17, 2026 9:01 PM - SEC Filing Form 4 ADMA BIOLOGICS, INC. For: Mar 16 Filed by: Grossman Adam S March 17, 2026 9:00 PM - SEC Filing Form 144 ADMA BIOLOGICS, INC. Filed by: Tade Brad L. March 10, 2026 9:45 PM - SEC Filing Form 4 ADMA BIOLOGICS, INC. For: Mar 06 Filed by: Kestenberg-Messina Kaitlin M. March 10, 2026 9:00 PM - SEC Filing Form 4 ADMA BIOLOGICS, INC. For: Mar 06 Filed by: Grossman Adam S March 10, 2026 9:00 PM - SEC Filing Form 144 ADMA BIOLOGICS, INC. Filed by: Kestenberg-Messina Kaitlin M. March 9, 2026 9:00 PM - SEC Filing Form 4 ADMA BIOLOGICS, INC. For: Mar 05 Filed by: ELMS STEVE March 9, 2026 9:15 AM - SEC Filing Full Article List